Amarin Corp Plc (AMRN)

[sts66]

Yeah, primary prevention (PP) was a failure, and I was really, really disappointed by that result - personally, because I'm taking V with hopes it prevents a CVE (stroke scares me the worst), and as a statin hater, I was looking forward to V being able to claim it's the only drug proven to prevent the first event. Whether that limits peak sales or not I have no idea - we've seen pro-V docs say they are or will take V for their own health despite them not having suffered a CVE yet, so we could see significant off label uses for PP. Which makes me wonder what will actually be on the R-IT label - will it include all at-risk patients, or just ones with established CVD?